Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CUMBERLAND PHARMACEUTICALS INC
Report date March 17, 2021 · Filed June 11, 2021
Section 16 reporting ended · disclosed 2021-06-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,803 |
Reported balance
After 2021-03-17 transaction · row 1
1 source rowRow 1 · 2021-03-17 · Grant · Acquired 1,000 · Balance 14,803 F1: Restricted stock award will vest 100% on March 17, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock award will vest 100% on March 17, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2021 Filed Jun 11, 2021 21:19 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $3.22 | $3,220.00 |
DisclosureSEC source: 0001209191-21-039933 · doc4.xml · nonDerivative · entry 1 Griggs Jonathan · CIK 0001490828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,803 F1 · shares: Restricted stock award will vest 100% on March 17, 2022. Read SEC document |
| March 23, 2020 Filed Apr 17, 2020 21:20 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $3.56 | $3,560.00 |
DisclosureSEC source: 0001209191-20-024889 · doc4.xml · nonDerivative · entry 1 Griggs Jonathan · CIK 0001490828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,803 F1 · shares: Restricted stock award will vest 100% on March 23, 2021. Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 21:13 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $5.98 | $5,980.00 |
DisclosureSEC source: 0001209191-19-021027 · doc4.xml · nonDerivative · entry 1 Griggs Jonathan · CIK 0001490828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,803 F1 · shares: Restricted stock award will vest 100% on March 18, 2020. Read SEC document |
| March 23, 2018 Filed Mar 23, 2018 21:43 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $6.70 | $6,700.00 |
DisclosureSEC source: 0001209191-18-021474 · doc4.xml · nonDerivative · entry 1 Griggs Jonathan · CIK 0001490828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,803 F1 · shares: Restricted stock award will vest 100% on March 20, 2019. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 21:22 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | SaleCommon Stock | 8,000 | $6.97 | $55,760.00 |
DisclosureSEC source: 0001209191-17-037366 · doc4.xml · nonDerivative · entry 1 Griggs Jonathan · CIK 0001490828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,803 F1 · shares: Shares sold to Cumberland Pharmaceuticals Inc. Read SEC document |
| April 07, 2017 Filed Apr 7, 2017 21:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $6.45 | $6,450.00 |
DisclosureSEC source: 0001209191-17-026320 · doc4.xml · nonDerivative · entry 1 Griggs Jonathan · CIK 0001490828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,803 F1 · shares: Restricted stock award will vest 100% on March 17, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.